Trends in Dispensed Opioid Analgesic Prescriptions to Children in South Carolina: 2010-2017

William T Basco1, Jenna L McCauley2, Jingwen Zhang3

  • 1Departments of Pediatrics, bascob@musc.edu.

Pediatrics
|February 2, 2021
PubMed

Insights

Opioid prescriptions for children decreased significantly, but the average daily dosage remained largely unchanged. Further improvements in opioid prescribing and dispensing for pediatric patients are needed.

Area of Science:

  • Pediatric pharmacology
  • Public health
  • Epidemiology

Background:

  • Published data indicate a decline in opioid prescribing and dispensing to children.
  • Few studies have evaluated all children within a single state or examined changes in mean daily opioid dosages.

Purpose of the Study:

  • To evaluate changes in the rate of dispensed opioid analgesics for children aged 0-18 years.
  • To examine changes in the mean daily opioid dosage dispensed to pediatric patients over an 8-year period.

Main Methods:

  • Utilized South Carolina's prescription drug monitoring program data from 2010-2017.
  • Analyzed opioid analgesic prescriptions dispensed to individuals aged 0-18 years.
  • Employed generalized linear regression to assess trends in prescription rates and mean daily morphine milligram equivalents (MMEs).

Main Results:

  • The quarterly rate of dispensed opioid prescriptions decreased by 35.6% from 2010 to 2017.
  • The most significant declines in prescription rates were observed among 18-year-olds (41.2%).
  • Mean daily MMEs per prescription decreased by 7.6% overall, but this reduction was primarily seen in children aged 0-9 years.

Conclusions:

  • Opioid analgesic prescriptions dispensed to children in South Carolina declined substantially between 2010 and 2017.
  • The mean daily MME dispensed per prescription showed a minimal decrease, indicating room for improvement in opioid stewardship for pediatric populations.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
660
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.0K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
591
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
103
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
106